Histone Deacetylases and Their Regulatory MicroRNAs in Hepatocarcinogenesis

被引:25
|
作者
Kim, Hyung Seok [1 ,2 ]
Shen, Qingyu [1 ,2 ]
Nam, Suk Woo [1 ,2 ,3 ]
机构
[1] Catholic Univ Korea, Coll Med, Dept Pathol, Seoul 06591, South Korea
[2] Catholic Univ Korea, Funct RNom Res Ctr, Seoul 06591, South Korea
[3] Catholic Univ Korea, Canc Evolut Res Ctr, Seoul 06591, South Korea
基金
新加坡国家研究基金会;
关键词
Histone Deacetylases; MicroRNAs; Carcinoma; Hepatocellular; HUMAN HEPATOCELLULAR-CARCINOMA; TUMOR-SUPPRESSOR; CELL-CYCLE; MESENCHYMAL TRANSITION; MALIGNANT PROGRESSION; EXPRESSION; APOPTOSIS; OVEREXPRESSION; CANCER; GENE;
D O I
10.3346/jkms.2015.30.10.1375
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A growing body of evidence suggests that epigenetic modifications are promising potential mechanisms in cancer research. Among the molecules that mediate epigenetic mechanisms, histone deacetylases (HDACs) are critical regulators of gene expression that promote formation of heterochromatin by deacetylating histone and non-histone proteins. Aberrant regulation of HDACs contributes to malignant transformation and progression in a wide variety of human cancers, including hepatocellular carcinoma (HCC), gastric cancer, lung cancer, and other cancers. Thus, the roles of HDACs have been extensively studied because of their potential as therapeutic targets. However, the underlying mechanism leading to deregulation of individual HDACs remains largely unknown. Some reports have suggested that functional microRNAs (miRNAs) modulate epigenetic effector molecules including HDACs. Here, we describe the oncogenic or tumor suppressive functions of HDAC families and their regulatory miRNAs governing HDAC expression in hepatocarcinogenesis.
引用
收藏
页码:1375 / 1380
页数:6
相关论文
共 50 条
  • [1] The interplay between microRNAs and histone deacetylases in neurological diseases
    Bourassa, Megan W.
    Ratan, Rajiv R.
    NEUROCHEMISTRY INTERNATIONAL, 2014, 77 : 33 - 39
  • [2] Inhibition of histone deacetylases in melanomaa perspective from bench to bedside
    Hornig, Eva
    Heppt, Markus V.
    Graf, Saskia A.
    Ruzicka, Thomas
    Berking, Carola
    EXPERIMENTAL DERMATOLOGY, 2016, 25 (11) : 831 - 838
  • [3] Histone deacetylases and cancer
    Barneda-Zahonero, Bruna
    Parra, Maribel
    MOLECULAR ONCOLOGY, 2012, 6 (06) : 579 - 589
  • [4] Tumour Expression of Histone Deacetylases in Uveal Melanoma
    Levinzon, Louis
    Madigan, Michele
    Vuong Nguyen
    Hasic, Enisa
    Conway, Max
    Cherepanoff, Svetlana
    OCULAR ONCOLOGY AND PATHOLOGY, 2019, 5 (03) : 153 - 161
  • [5] Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma
    Phimmachanh, Monica
    Han, Jeremy Z. R.
    O'Donnell, Yolande E., I
    Latham, Sharissa L.
    Croucher, David R.
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2020, 8
  • [6] Regulatory signal transduction pathways for class IIa histone deacetylases
    Parra, Maribel
    Verdin, Eric
    CURRENT OPINION IN PHARMACOLOGY, 2010, 10 (04) : 454 - 460
  • [7] Combined targeting of histone deacetylases and hedgehog signaling enhances cytoxicity in pancreatic cancer
    Chun, Stephen G.
    Zhou, Weiqiang
    Yee, Nelson S.
    CANCER BIOLOGY & THERAPY, 2009, 8 (14) : 1328 - 1339
  • [8] Role for Class I histone deacetylases in multidrug resistance
    Xu, Yichun
    Jiang, Zijing
    Yin, Peihao
    Li, Qi
    Liu, Jianwen
    EXPERIMENTAL CELL RESEARCH, 2012, 318 (03) : 177 - 186
  • [9] The role of histone deacetylases in inflammatory respiratory diseases: an update
    Pan, Sicen
    Wang, Xiangdong
    Jiao, Jian
    Zhang, Luo
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2024, 20 (10) : 1193 - 1203
  • [10] Chemical genomics reveals histone deacetylases are required for core regulatory transcription
    Gryder, Berkley E.
    Wu, Lei
    Woldemichael, Girma M.
    Pomella, Silvia
    Quinn, Taylor R.
    Park, Paul M. C.
    Cleveland, Abigail
    Stanton, Benjamin Z.
    Song, Young
    Rota, Rossella
    Wiest, Olaf
    Yohe, Marielle E.
    Shern, Jack F.
    Qi, Jun
    Khan, Javed
    NATURE COMMUNICATIONS, 2019, 10 (1)